BamSEC and AlphaSense Join Forces
Learn More

Vitro Biopharma, Inc.

Formerly OTC: VODG

Material Contracts Filter

EX-10.2
from 8-K 20 pages Vitro Biopharma, Inc. Consolidated, Amended and Restated Senior Secured Convertible Note
12/34/56
EX-10.1
from 8-K 2 pages Increase and Consolidation Amendment and Restatement of Senior Secured Convertible Notes
12/34/56
EX-10.46
from S-1/A 3 pages Amendment to 6% Unsecured Promissory Note
12/34/56
EX-10.45
from S-1/A 3 pages Amendment to 4% Unsecured Promissory Note
12/34/56
EX-10.41
from S-1/A 10 pages Strictly Confidential
12/34/56
EX-10.40
from S-1/A 6 pages Consulting Agreement
12/34/56
EX-10.4
from 8-K 4 pages Annex B Lock-Up Agreement
12/34/56
EX-10.3
from 8-K 12 pages Annex a Pre-Funded Common Stock Purchase Warrant Vitro Biopharma, Inc
12/34/56
EX-10.2
from 8-K 5 pages Vitro Biopharma, Inc. 3200 Cherry Creek Drive South, Suite 720 Denver, Colorado 80209 June 21, 2024
12/34/56
EX-10.1
from 8-K 2 pages Vitro Biopharma, Inc. 3200 Cherry Creek Drive South, Suite 720 Denver, Colorado 80209 June 21, 2024
12/34/56
EX-10.1
from 8-K 19 pages Appendix B Form of Senior Secured Convertible Note
12/34/56
EX-10.47
from S-1/A 3 pages Amendment to 6% Unsecured Promissory Note
12/34/56
EX-10.46
from S-1/A 3 pages Amendment to 4% Unsecured Promissory Note
12/34/56
EX-10.41
from S-1/A 10 pages Strictly Confidential
12/34/56
EX-10.40
from S-1/A 6 pages Consulting Agreement
12/34/56
EX-10.38
from 10-K 11 pages Convertible Note and Warrant Purchase Agreement
12/34/56
EX-10.37
from 10-K 3 pages Convertible Promissory Note
12/34/56
EX-10.36
from 10-K 3 pages Certain Identified Information, Marked by [***], Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Would Likely Cause Competitive Harm to the Company, if Publicly Disclosed. Memorandum of Understanding by and Between Vitro Biopharma, Inc. and Dr. Jack Zamora
12/34/56
EX-10.35
from 10-K 18 pages Certain Identified Information, Marked by [***], Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Would Likely Cause Competitive Harm to the Company, if Publicly Disclosed. Supply Agreement
12/34/56
EX-10.34
from 10-K 4 pages Standstill Agreement
12/34/56